Clinical Trial of Fosbretabulin in Anaplastic Cancer of the Thyroid (FACT)
Thursday May 28, 2009
If you or someone you know has anaplastic thyroid cancer, you'll want to learn more about the FACT clinical trial of the drug fosbretabulin, which is also known as Zybrestat. The trial is recruiting patients with regionally-advanced or metastatic anaplastic thyroid cancer at sites in the United States, Eastern and Western Europe, Asia, and the Middle East.
You can find out more at the Clinical Trial: FACT - Fosbretabulin in Anaplastic Cancer of the Thyroid page, hosted by drugmaker Oxigene.
Also, full information on sites for the trial and how to enroll and participate is located at the National Institutes of Health Clinical Trials.gov page, Study of Combretastatin and Paclitaxel/Carboplatin in the Treatment of Anaplastic Thyroid Cancer.
More Information on Anaplastic Thyroid Cancer
Photo: clipart.com
Comments
Hi Mary,
I wasn’t sure how to contact you.
Wondering if you’ve read the research regarding low-dose Naltrexone for autoimmune diseases. I’ve read some accounts of thyroid antibodies lowering after taking LDN and thus having to lower thyroid medication due to hyper symptoms. Do you know anything about this?
Also, any thoughts on resveratrol and Hashimoto’s.
Thank you.